Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;28(5):229-239.
doi: 10.1007/s12471-020-01367-4.

Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions

P P T de Jaegere  1 , A de Weger  2 , P den Heijer  3 , M Verkroost  4 , J Baan  5 , T de Kroon  6 , Y America  7 , G J Brandon Bravo Bruinsma  8
Affiliations
Review

Treatment decision for transcatheter aortic valve implantation: the role of the heart team : Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions

P P T de Jaegere et al. Neth Heart J. 2020 May.

Abstract

The current paper presents a position statement of the Dutch Working Group of Transcatheter Heart Valve Interventions that describes which patients with aortic stenosis should be considered for transcatheter aortic valve implantation and how this treatment proposal/decision should be made. Given the complexity of the disease and the assessment of its severity, in particular in combination with the continuous emergence of new clinical insights and evidence from physiological and randomised clinical studies plus the introduction of novel innovative treatment modalities, the gatekeeper of the treatment proposal/decision and, thus, of qualification for cost reimbursement is the heart team, which consists of dedicated professionals working in specialised centres.

Keywords: Aortic stenosis; Heart team; Surgical aortic valve replacement; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

P.P.T. de Jaegere, A. de Weger, P. den Heijer, M. Verkroost, J. Baan, T. de Kroon, Y. America and G.J. Brandon Bravo Bruinsma declare that they have no competing interests.

References

    1. Braunwald E. Aortic stenosis. Then and now. Circulation. 2018;137:2099–2100. doi: 10.1161/CIRCULATIONAHA.118.033408. - DOI - PubMed
    1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–3008. doi: 10.1161/01.CIR.0000047200.36165.B8. - DOI - PubMed
    1. de Jaegere PPT. How to move toward the least invasive transfemoral transcatheter aortic valve implantation procedure? Circ Cardiovasc Interv. 2014;7:439–440. doi: 10.1161/CIRCINTERVENTIONS.114.001729. - DOI - PubMed
    1. Andersen HR, Knudsen LL, Hasenkam MJ. Transluminal implantation of artificial heart valves. Description of a new balloon expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13:704–708. doi: 10.1093/oxfordjournals.eurheartj.a060238. - DOI - PubMed
    1. de Jaegere PPT, Kappetein AP, Knook M, et al. Percutaneous aortic valve replacement in a patient who could not undergo surgical treatment. A case report with the CoreValve aortic valve prosthesis. EuroIntervention. 2006;1:475–479. - PubMed

LinkOut - more resources